Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.
Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...
Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...
Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...
Patients with acute COPD exacerbation should be treated with systemic corticosteroids, antibiotics and NPPV. Systemic corticosteroids reduce treatment failures in both in-hospital and outpatient ...
The incidence of a first moderate or severe chronic obstructive pulmonary disease exacerbation was higher in patients ... a once-daily dry powder inhaler for treatment of COPD in routine clinical ...
2010;67(13):1061-1069. Considering all of the data and their limitations, questions still remain regarding the optimal treatment of COPD exacerbations. The data of deJong et al. [30] showed no ...
To that end, GOLD guidelines for COPD recommend tailoring treatment based on risk of exacerbation and symptom severity as well as on patient preference, including cost, availability, and the user’s ...
The researchers found that the incidence of a first moderate or severe COPD exacerbation was higher in patients who received budesonide-glycopyrrolate-formoterol (hazard ratio, 1.09; 95 percent ...
Background Some patients with COPD ... FE (≥2 exacerbations or 1 hospitalisation due to AECOPD in the previous year) or IE (≤1 exacerbation in the previous year), AECOPD being defined by the ...
We included patients with three outpatient claims or one inpatient ... with pneumonia were similar between the two treatment groups (1.03 (0.93 to 1.14)). Higher hazards of first moderate or severe ...
England: A novel way of scanning lungs can demonstrate the impact of treatment on lung function ... chronic obstructive pulmonary disease (COPD), and patients who have received a lung transplant.